Stock listing

Frankfurt:2X10 Abivax SA Aktie

German listing (Frankfurt) of Abivax SA · home listing Euronext:ABVX

Follow Abivax SA into a list and get an email when it puts out news.

Share price · FWB:2X10

€74.00 EUR -3.50 (-4.5%)

Close on Nov 17, 2026

This year -29.1% · daily closes, Dec 1, 2025 – Nov 6, 2026, adjusted for splits
Day range
€74.00 – €74.00 EURNov 17, 2026
Volume
40 sharesNov 17, 2026
Market cap
€6.46B EURAt the close on Nov 17, 2026 · price × 87.27M shares outstanding
Traded on an average day
€6,332 EURMedian day 0 shares · 46 days with no trades · last 3 months, Aug 17, 2026 – Nov 6, 2026
Abivax SA logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Euronext:ABVX · Home€75.50 EUR-1.40 (-1.8%)128,059€75.20€76.15€74.25€76.90Close on Nov 17, 2026
NASDAQ:ABVX$82.10 USD-1.51 (-1.8%)1,372,710$82.86$84.31$81.83$83.61Close on Nov 17, 2026
LSE:0RA9€75.15 EUR-1.75 (-2.3%)2,062€76.00€76.00€74.60€76.90Close on Nov 17, 2026
OTC:AAVXF$84.80 USD0.00 (0.0%)—$84.80$84.80$84.80$84.80Close on Nov 6, 2026
Frankfurt:2X1€77.00 EUR+1.15 (+1.5%)101€74.65€77.00€74.65€75.85Close on Nov 17, 2026
Frankfurt:2X10€74.00 EUR-3.50 (-4.5%)40€74.00€74.00€74.00€77.50Close on Nov 17, 2026

Daily closes

Last 3 months, Aug 17, 2026 – Nov 6, 2026 · FWB:2X10 · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€75.03-0.561-0.7%€74.20€75.92€73.350
€75.59-2.565-3.3%€78.52€78.88€75.370
€78.16+0.244+0.3%€77.75€78.23€77.731,190
€77.91+3.178+4.3%€73.01€78.87€72.70800
€74.73-3.62-4.6%€76.89€76.97€74.510
€78.35+0.0280.0%€78.35€78.35€78.352
€78.33+1.241+1.6%€78.33€78.33€78.331,200
€77.09-0.816-1.0%€77.09€77.09€77.09200
€77.90+0.384+0.5%€75.79€78.40€75.370
€77.52-1.565-2.0%€78.03€78.38€77.1414
€79.08-2.284-2.8%€79.08€79.08€79.080
€81.37-1.327-1.6%€81.37€81.37€81.370
€82.69+0.826+1.0%€81.59€83.01€80.870
€81.87+3.763+4.8%€78.71€82.04€78.610
€78.10-3.213-4.0%€78.10€78.10€78.100
€81.32+0.625+0.8%€80.57€81.68€80.340
€80.69+5.71+7.6%€76.37€81.01€75.390
€74.98-1.661-2.2%€74.98€74.98€74.980
€76.64-1.561-2.0%€76.93€77.04€76.640
€78.20+0.975+1.3%€78.20€78.20€78.200
€77.23+0.698+0.9%€77.23€77.23€77.23124
€76.53+0.454+0.6%€76.53€76.53€76.53102
€76.08-2.67-3.4%€76.56€76.95€75.790
€78.75-3.253-4.0%€78.78€78.78€78.030
€82.00-0.0340.0%€82.00€82.00€82.000
€82.03-3.294-3.9%€82.03€82.03€82.03300
€85.33+0.59+0.7%€85.49€85.53€85.280
€84.74+0.963+1.1%€84.74€84.74€84.740
€83.78+4.553+5.7%€83.78€83.78€83.780
€79.22-0.623-0.8%€79.22€79.22€79.220
€79.85-1.85-2.3%€79.85€79.85€79.850
€81.70+0.238+0.3%€81.41€82.31€80.980
€81.46-4.128-4.8%€85.64€85.92€81.400
€85.59-3.558-4.0%€89.23€89.23€84.920
€89.14-1.825-2.0%€90.98€91.70€88.840
€90.97+1.421+1.6%€91.29€91.29€90.388
€89.55-2.584-2.8%€89.55€89.55€89.550
€92.13+0.086+0.1%€92.13€92.13€92.13100
€92.05-6.679-6.8%€95.60€96.22€92.030
€98.72-0.765-0.8%€100.48€101.08€97.850
€99.49-4.302-4.1%€99.49€99.49€99.490
€103.79+2.354+2.3%€103.79€103.79€103.790
€101.44+1.126+1.1%€100.37€102.76€100.310
€100.31+3.919+4.1%€96.83€100.99€96.150
€96.39+0.283+0.3%€96.39€96.39€96.390
€96.11+1.644+1.7%€96.11€96.11€96.11216
€94.47-1.124-1.2%€94.47€94.47€94.470
€95.59+1.445+1.5%€95.59€95.59€95.590
€94.14-2.266-2.4%€94.14€94.14€94.140
€96.41-0.544-0.6%€96.41€96.41€96.410
€96.95-1.636-1.7%€96.95€96.95€96.95216
€98.59-1.186-1.2%€98.59€98.59€98.590
€99.78+0.972+1.0%€99.78€99.78€99.780
€98.80+0.973+1.0%€98.80€98.80€98.800
€97.83-1.772-1.8%€97.83€97.83€97.830
€99.60-1.952-1.9%€99.60€99.60€99.60204
€101.56-0.181-0.2%€101.56€101.56€101.560
€101.74+1.454+1.4%€101.74€101.74€101.740
€100.28-1.812-1.8%€100.28€100.28€100.280
€102.09-3.091-2.9%€101.61€103.86€101.320
Ticker
Frankfurt:2X10
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Frankfurt
Currency
EUR

What changed lately

Calls

Replays

  • Abivax (Euronext:ABVX) Q4 2023 Earnings Call

    Mon, Apr 08, 2024 · 8:30 AM ET

    Watch Transcript

Latest news

All Abivax SA news

Financings

  • Public offering of american Depositary Shares

    Jul 6, 2026

    Closed: US$920M raised · Leerink Partners +5

    Dealers: Leerink Partners (co-lead), Morgan Stanley (co-lead), Piper Sandler (co-lead), Guggenheim Securities (co-lead), LifeSci Capital, Van Lanschot Kempen

    Use of proceeds: Together with existing cash, to finance operations into the fourth quarter of 2029

    Closed Jul 6, 2026

  • Public offering of american Depositary Shares

    Jul 2, 2026

    Made bigger: about US$920M · US$125 a share · Leerink Partners +5

    Dealers: Leerink Partners (co-lead), Morgan Stanley & Co. LLC (co-lead), Piper Sandler & Co. (co-lead), Guggenheim Securities, LLC (co-lead), LifeSci Capital, Van Lanschot Kempen

    Use of proceeds: Potential US commercialization of obefazimod, clinical R&D mainly in ulcerative colitis and Crohn's disease, and general corporate purposes

    Announced Jun 30, 2026 · Made bigger Jul 1, 2026 · Made bigger Jul 2, 2026

  • Public offering of american Depositary Shares

    Jul 28, 2025

    Closed: US$747.5M raised · US$64 a share · Leerink Partners +5

    Dealers: Leerink Partners (co-lead), Piper Sandler & Co. (co-lead), Guggenheim Securities, LLC (co-lead), LifeSci Capital, BTIG, Van Lanschot Kempen

    Use of proceeds: Finance operations into the fourth quarter of 2027, giving 12 months of cash runway after the planned NDA submission for Ulcerative Colitis

    Announced Jul 23, 2025 · Update Jul 24, 2025 · Made bigger Jul 25, 2025 · Closed Jul 28, 2025

Read by 6ix AI from the company's releases

Decks

Abivax SA on 6ix

Sector
Health care
Industry
Biotechnology
News releases
30 in the last 12 months · 49 in all · newest Nov 2, 2026 · oldest 2025
Calls
1 call with a replay · 1 with a transcript · latest Apr 8, 2024
Decks
39 decks · latest July 2026

Where Abivax SA is listed

ListingExchangeCountryCurrency
Euronext:ABVX · Home listingEuronextFranceEUR
NASDAQ:ABVXNASDAQUnited StatesUSD
LS Exchange:A14UQCLS ExchangeGermanyEUR
gettex:2X1gettexGermanyEUR
LSE:0RA9LSEUnited KingdomEUR
Xetra:2X1XetraGermanyEUR
Tradegate:2X1TradegateGermanyEUR
OTC:AAVXFOTCUnited StatesUSD
Lang & Schwarz:A14UQCLang & SchwarzGermanyEUR
Aquis:ABVXPAquisUnited KingdomEUR
Frankfurt:2X1FrankfurtGermanyEUR
gettex:2X10gettexGermanyEUR
BX Swiss:ABVXBX SwissSwitzerlandCHF
Dusseldorf:2X1DusseldorfGermanyEUR
Lang & Schwarz:A3EWCPLang & SchwarzGermanyEUR
Munich:2X1MunichGermanyEUR
Hamburg:2X1HamburgGermanyEUR
Aquis:ABVXPAquisUnited KingdomEUR
BOATS:ABVXBOATSUnited StatesUSD
Frankfurt:2X10 · This pageFrankfurtGermanyEUR
LS Exchange:A3EWCPLS ExchangeGermanyEUR
Stuttgart:2X1StuttgartGermanyEUR
Turquoise:ABVXPTurquoiseUnited KingdomEUR
VIE:ABVXViennaAustriaEUR
Dusseldorf:2X10DusseldorfGermanyEUR
Hamburg:2X10HamburgGermanyEUR
Munich:2X10MunichGermanyEUR
Stuttgart:2X10StuttgartGermanyEUR
Tradegate:2X10TradegateGermanyEUR
Hanover:2X1HanoverGermanyEUR

Log in to ask 6ix AI your own questions about Abivax SA.